Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition
Year: 2007
Type: article
Study design: Observational Study
Abstract: Western style diets and lifestyles are associated with increasing rates of obesity, diabetes and insulin resistance. Higher circulating insulin levels may modulate cell proliferation and apoptosis either directly or indirectly by increasing the bioactivity of IGF-I and decreasing the bioactivity of some of its binding proteins. The objective of this study was to determine the association of increasing levels of serum C-peptide, a biomarker of pancreatic insulin secretion, and IGF binding proteins (IGFBP) -1 and -2 with colorectal cancer risk in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), a large cohort involving 10 Western European countries. A total of 1,078 colorectal cancer cases were matched (age, date of blood donation, fasting status, gender, study center) to an equal number of control subjects. Relative cancer risks were estimated using conditional logistic regression models. Serum C-peptide concentration was positively associated with an increased colorectal cancer risk for the highest versus the lowest quintile (OR=1.56, 95% CI=1.16-2.09, p(trend)<0.01), which was slightly attenuated after adjustment for BMI and physical activity (OR=1.37, 95% CI=1.00-1.88, p(trend)=0.10). When stratified by anatomical site, the cancer risk was stronger in the colon (OR=1.67, 95% CI=1.14-2.46, p(trend)<0.01) than in the rectum (OR=1.42, 95% CI=0.90-2.25, p(trend)=0.35). The cancer risk estimates were not heterogeneous by gender or fasting status. No clear colorectal cancer risk associations were observed for IGFBP-1 or -2. This large prospective study confirms that hyperinsulinemia, as determined by C-peptide levels, is associated with an increased colorectal cancer risk.
Source: International Journal of Cancer
DOI: 10.1002/ijc.22697
Authors: Mazda Jenab, Elio Riboli, Rebecca J. Cleveland, Teresa Norat, Sabina Rinaldi, Alexandra Nieters, Carine Biessy, Ann Tjønneland, Anja Olsen, Kim Overvad, Henning Grønbæk, Françoise Clavel‐Chapelon, Marie‐Christine Boutron‐Ruault, Jakob Linseisen, Heiner Boeing, Tobias Pischon, Dimitrios Trichopoulos, Eleni Oikonomou, Antonia Trichopoulou, Salvatore Panico, Paolo Vineis, Franco Berrino, Rosario Tumino, Giovanna Masala, Petra H. Peters, Carla H. van Gils, H. Bas Bueno‐de‐Mesquita, Marga C. Ocké, Eiliv Lund, Michelle A. Mendez, María José Tormo, Aurelio Barricarte, Carmen Martínez‐García, Miren Dorronsoro, José Ramón Quirós, Göran Hallmans, Richard Palmqvist, Göran Berglund, Jonas Manjer, Timothy Key, Naomi E. Allen, Sheila Bingham, Kay‐Tee Khaw, Anne Cust, Rudolf Kaaks
Institutions: Centre international de recherche sur le cancer, Imperial College London, University of North Carolina at Chapel Hill, German Cancer Research Center, Danish Cancer Society, Aalborg University Hospital, Aarhus University Hospital, Inserm, Institut Gustave Roussy, German Institute of Human Nutrition, National and Kapodistrian University of Athens, University of Naples Federico II, Azienda Usl 8 Arezzo, University Medical Center Utrecht, National Institute for Public Health and the Environment, UiT The Arctic University of Norway, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Instituto de Salud Pública de Navarra, Andalusian School of Public Health, Umeå University, University of Oxford, University of Cambridge
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Deutsches Krebsforschungszentrum, Wellcome Trust, Cancer Research UK, British Heart Foundation, Stroke Association, European Commission, Institut National de la Santé et de la Recherche Médicale, Bundesministerium für Bildung und Forschung, Cancerfonden, Ligue Contre le Cancer, Deutsche Krebshilfe, Medical Research Council, World Cancer Research Fund, National Cancer Institute
OpenAlex ID: W2099469496
